The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...

A team led by researchers at UNC-Chapel Hill have developed an innovative computer model of blood flow in the human heart that promises to transform how we understand, diagnose, and treat heart ...

Myotonic Dystrophy Type 1 (DM1) is the most common adult-onset form of muscular dystrophy and a condition that severely affects multiple organs including skeletal muscle, heart, brain and the ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

The U.S. Federal Aviation Administration (FAA) broadened a standard for normal heart function in pilots because medical evidence showed no symptoms or additional health risk up to the raised threshold ...